Schedule 13D ownership disclosure
Boston Therapeutics, Inc.
Security class unavailable · CUSIP: 05351T100
Event date: 2018-09-21
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 10.3000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-19-009775
- Form type
- SC 13D
- Filer
- BIOXYTRAN, INC
- CIK
- CIK 1445815
- Filed
- May 30, 2019
- Reporting period
- Sep 21, 2018
- Description
- Schedule 13D beneficial ownership